Dr. Craig Moskowitz, MD

NPI: 1053402503
Total Payments
$190,115
2024 Payments
$2,884
Companies
22
Transactions
138
Medicare Patients
670
Medicare Billing
$104,123

Payment Breakdown by Category

Consulting$101,685 (53.5%)
Other$44,555 (23.4%)
Travel$32,514 (17.1%)
Education$7,961 (4.2%)
Food & Beverage$3,400 (1.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $101,685 36 53.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $37,753 4 19.9%
Travel and Lodging $32,514 27 17.1%
Education $7,961 2 4.2%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,603 1 1.9%
Food and Beverage $3,400 66 1.8%
Honoraria $3,200 2 1.7%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals International, Inc. $63,842 11 $0 (2019)
Merck Sharp & Dohme LLC $23,352 18 $0 (2022)
Seattle Genetics, Inc. $19,986 35 $0 (2019)
Millennium Pharmaceuticals, Inc. $17,355 4 $0 (2017)
E.R. Squibb & Sons, L.L.C. $11,690 5 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $10,700 2 $0 (2022)
AstraZeneca Pharmaceuticals LP $10,682 12 $0 (2024)
Incyte Corporation $6,150 5 $0 (2022)
Seagen Inc. $4,630 8 $0 (2023)
ADC Therapeutics America, Inc. $4,284 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,884 5 AstraZeneca Pharmaceuticals LP ($2,055)
2023 $4,590 8 Seagen Inc. ($4,452)
2022 $21,090 14 Takeda Pharmaceuticals U.S.A., Inc. ($6,500)
2021 $4,880 5 Incyte Corporation ($2,768)
2020 $10,284 6 Takeda Pharmaceuticals U.S.A., Inc. ($4,200)
2019 $33,410 21 Takeda Pharmaceuticals International, Inc. ($26,980)
2018 $53,988 31 Takeda Pharmaceuticals International, Inc. ($23,962)
2017 $58,989 48 Millennium Pharmaceuticals, Inc. ($17,355)

All Payment Transactions

138 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/06/2024 PFIZER INC. ADCETRIS (Biological) Food and Beverage In-kind items and services $11.76 General
Category: Oncology
10/26/2024 PFIZER INC. ADCETRIS (Biological) Food and Beverage In-kind items and services $85.48 General
Category: Oncology
10/25/2024 Medtronic, Inc. MICRA (Device) Food and Beverage In-kind items and services $32.07 General
Category: Pacemakers
08/01/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Consulting Fee Cash or cash equivalent $2,055.00 General
Category: Oncology
05/15/2024 PFIZER INC. ADCETRIS (Biological) Honoraria Cash or cash equivalent $700.00 General
Category: Oncology
12/11/2023 Seagen Inc. Food and Beverage In-kind items and services $34.94 General
11/22/2023 Seagen Inc. ADCETRIS (Biological) Consulting Fee Cash or cash equivalent $2,100.00 General
Category: Oncology
11/16/2023 Seagen Inc. ADCETRIS (Biological) Consulting Fee Cash or cash equivalent $2,275.00 General
Category: Oncology
08/15/2023 Seagen Inc. ADCETRIS (Biological) Food and Beverage In-kind items and services $18.98 General
Category: Oncology
06/14/2023 ADC Therapeutics America, Inc. Food and Beverage In-kind items and services $83.50 General
06/14/2023 Genentech USA, Inc. Gazyva (Biological), Lunsumio, Polivy Food and Beverage In-kind items and services $31.58 General
Category: BioOncology
04/04/2023 Genentech USA, Inc. Lunsumio (Biological) Food and Beverage In-kind items and services $23.11 General
Category: BioOncology
01/07/2023 Seagen Inc. Food and Beverage In-kind items and services $22.64 General
12/22/2022 Kite Pharma, Inc. Yescarta (Drug) Consulting Fee Cash or cash equivalent $2,770.00 General
Category: CELLT
12/22/2022 Kite Pharma, Inc. Yescarta (Drug) Travel and Lodging In-kind items and services $317.06 General
Category: CELLT
12/16/2022 Incyte Corporation Consulting Fee Cash or cash equivalent $615.00 General
12/10/2022 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $50.00 General
12/09/2022 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $84.79 General
Category: Oncology
12/09/2022 Seagen Inc. Food and Beverage In-kind items and services $22.47 General
12/08/2022 Kite Pharma, Inc. Yescarta (Drug) Food and Beverage In-kind items and services $114.58 General
Category: CELLT
12/08/2022 Kite Pharma, Inc. Yescarta (Drug) Food and Beverage In-kind items and services $22.90 General
Category: CELLT
12/01/2022 Merck Sharp & Dohme LLC Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,270.00 General
08/07/2022 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Consulting Fee Cash or cash equivalent $1,883.75 General
Category: Oncology
07/21/2022 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $115.88 General
Category: Oncology
06/27/2022 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $6,500.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 158 260 $89,529 $22,959
2022 4 197 356 $125,048 $33,169
2021 4 175 311 $109,979 $29,826
2020 4 140 245 $78,415 $18,169
Total Patients
670
Total Services
1,172
Medicare Billing
$104,123
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 54 101 $30,199 $7,399 24.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 28 43 $18,447 $5,104 27.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 34 57 $17,043 $4,532 26.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 18 31 $13,299 $3,712 27.9%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 11 11 $7,260 $1,297 17.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 13 17 $3,281 $915.27 27.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 47 92 $39,468 $11,321 28.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 55 111 $33,189 $8,369 25.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 19 37 $15,873 $4,493 28.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 26 54 $16,146 $4,292 26.6%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 18 18 $11,880 $2,473 20.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 17 27 $5,211 $1,340 25.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 15 17 $3,281 $880.13 26.8%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 34 71 $30,459 $8,728 28.7%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 41 90 $26,910 $7,173 26.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 25 53 $15,847 $4,368 27.6%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 16 25 $10,725 $2,976 27.7%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 15 15 $9,900 $2,480 25.0%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 11 11 $7,260 $1,655 22.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 17 26 $5,018 $1,372 27.3%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 16 20 $3,860 $1,074 27.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 50 107 $31,993 $7,516 23.5%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 24 45 $19,305 $4,460 23.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 37 61 $11,773 $2,769 23.5%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 16 16 $10,560 $2,435 23.1%

About Dr. Craig Moskowitz, MD

Dr. Craig Moskowitz, MD is a Medical Oncology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053402503.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Craig Moskowitz, MD has received a total of $190,115 in payments from pharmaceutical and medical device companies, with $2,884 received in 2024. These payments were reported across 138 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($101,685).

As a Medicare-enrolled provider, Moskowitz has provided services to 670 Medicare beneficiaries, totaling 1,172 services with total Medicare billing of $104,123. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Medical Oncology
  • Other Specialties Medical Oncology
  • Location Miami, FL
  • Active Since 09/28/2006
  • Last Updated 05/07/2018
  • Taxonomy Code 207RX0202X
  • Entity Type Individual
  • NPI Number 1053402503

Products in Payments

  • ADCETRIS (Biological) $37,085
  • Kazano (Drug) $26,980
  • OPDIVO (Biological) $11,690
  • CALQUENCE (Drug) $10,621
  • SGN19A (Biological) $4,415
  • ENTYVIO (Biological) $4,200
  • KYMRIAH (Biological) $3,881
  • Yescarta (Drug) $3,225
  • UKONIQ (Drug) $2,080
  • MONJUVI (Drug) $1,230
  • Sprint Quattro (Device) $146.69
  • BRUKINSA (Drug) $84.79
  • Arctic Front (Device) $72.64
  • Micra (Device) $64.16
  • CareLink (Device) $55.27
  • Reveal LINQ (Device) $46.05
  • Claria MRI (Device) $39.75
  • MICRA (Device) $32.07
  • Gazyva (Biological) $31.58
  • Lunsumio (Biological) $23.11

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Oncology Doctors in Miami